1. Home
  2. ATLN vs CERS Comparison

ATLN vs CERS Comparison

Compare ATLN & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLN
  • CERS
  • Stock Information
  • Founded
  • ATLN 2014
  • CERS 1991
  • Country
  • ATLN United States
  • CERS United States
  • Employees
  • ATLN N/A
  • CERS N/A
  • Industry
  • ATLN
  • CERS EDP Services
  • Sector
  • ATLN
  • CERS Technology
  • Exchange
  • ATLN NYSE
  • CERS Nasdaq
  • Market Cap
  • ATLN 269.5M
  • CERS 347.3M
  • IPO Year
  • ATLN 2021
  • CERS 1997
  • Fundamental
  • Price
  • ATLN $3.53
  • CERS $1.86
  • Analyst Decision
  • ATLN
  • CERS Buy
  • Analyst Count
  • ATLN 0
  • CERS 3
  • Target Price
  • ATLN N/A
  • CERS $3.17
  • AVG Volume (30 Days)
  • ATLN 32.2K
  • CERS 1.7M
  • Earning Date
  • ATLN 01-01-0001
  • CERS 03-04-2025
  • Dividend Yield
  • ATLN N/A
  • CERS N/A
  • EPS Growth
  • ATLN N/A
  • CERS N/A
  • EPS
  • ATLN N/A
  • CERS N/A
  • Revenue
  • ATLN $429,260,149.00
  • CERS $176,229,000.00
  • Revenue This Year
  • ATLN N/A
  • CERS $18.57
  • Revenue Next Year
  • ATLN N/A
  • CERS $10.80
  • P/E Ratio
  • ATLN N/A
  • CERS N/A
  • Revenue Growth
  • ATLN 5.50
  • CERS 14.71
  • 52 Week Low
  • ATLN $1.30
  • CERS $1.38
  • 52 Week High
  • ATLN $8.98
  • CERS $2.59
  • Technical
  • Relative Strength Index (RSI)
  • ATLN N/A
  • CERS 52.01
  • Support Level
  • ATLN N/A
  • CERS $1.89
  • Resistance Level
  • ATLN N/A
  • CERS $2.24
  • Average True Range (ATR)
  • ATLN 0.00
  • CERS 0.14
  • MACD
  • ATLN 0.00
  • CERS -0.00
  • Stochastic Oscillator
  • ATLN 0.00
  • CERS 24.00

About ATLN ATLANTIC INTERNATIONAL CORP

Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: